A clinical study investigating the pharmacokinetic interaction between NN703 (tabimorelin), a potential inhibitor of CYP3A4 activity, and midazolam, a CYP3A4 substrate (Q34180397)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A clinical study investigating the pharmacokinetic interaction between NN703 (tabimorelin), a potential inhibitor of CYP3A4 activity, and midazolam, a CYP3A4 substrate |
scientific article |
Statements
1 reference
A clinical study investigating the pharmacokinetic interaction between NN703 (tabimorelin), a potential inhibitor of CYP3A4 activity, and midazolam, a CYP3A4 substrate (English)
1 reference
Milan Zdravkovic
1 reference
Anette K Olsen
1 reference
Tina Christiansen
1 reference
Rainer Schulz
1 reference
Mitchell E Taub
1 reference
Mikael S Thomsen
1 reference
Michael H Rasmussen
1 reference
Mapoko M Ilondo
1 reference
6 February 2003
1 reference
1 reference
58
1 reference
10
1 reference
683-688
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference